IntrinsicIntrinsic
← All summaries

Charlton Aria Acquisition Corp

CHARU
Financials & Chart →

Business Summary

Charlton Aria Acquisition Corporation is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), incorporated in the Cayman Islands on March 22, 2024 . Its sole purpose is to effect a business combination, such as a merger, share exchange, asset acquisition, share purchase, recapitalization, or reorganization, with one or more operating businesses or entities . The company has not engaged in any operations nor generated any revenue to date, classifying it as a "shell company" under the Securities Exchange Act of 1934 . Its business model is entirely focused on identifying and acquiring a target business, leveraging the public company structure as an alternative to a traditional initial public offering for the target .

The company's management team intends to focus on creating shareholder value by improving operational efficiency and scaling revenue organically or through acquisitions . Key acquisition criteria include seeking businesses with strong management teams, underexploited expansion opportunities, long-term revenue visibility with defensible market positions, and those that would benefit from being a U.S. public company . The company aims for target companies near an anticipated inflection point, such as those requiring additional management expertise, capable of innovating new products or services, or where improved profitability can be achieved through growth-facilitating acquisitions .

For the period from March 22, 2024 (inception) through December 31, 2024, Charlton Aria Acquisition Corporation reported a net income of $266,838 . This income was primarily driven by a dividend earned on investments held in the trust account of $657,624 , interest income of $2,612 , and a change in the fair value of over-allotment option liability of $197,895 . These positive contributions were partially offset by formation and operating costs of $341,598 and stock-based compensation expense of $249,695 . As of December 31, 2024, the company held cash of $447,419 and had investments held in its trust account totaling $85,870,124 . Total current assets were $456,784 , and total assets were $86,326,908 . Current liabilities amounted to $49,634 , including accounts payable and accrued expenses of $35,884 and due to related parties of $13,750 . The company also reported a deferred underwriting commission payable of $1,700,000 , bringing total liabilities to $1,749,634 . Shareholders' deficit was $(1,292,850) , with an accumulated deficit of $(1,293,097) . Basic and diluted income per share for Class A ordinary shares subject to possible redemption was $0.07 , based on 1,917,254 weighted average shares outstanding . Basic and diluted net loss per share for non-redeemable Class A and Class B ordinary shares was also $0.07 , based on 1,989,982 weighted average shares outstanding .

The company consummated its initial public offering (IPO) on October 25, 2024, selling 7,500,000 units at $10.00 per unit, generating gross proceeds of $75,000,000 . Simultaneously, a private placement of 240,000 units to the sponsor generated $2,400,000 . On November 19, 2024, the underwriters partially exercised their over-allotment option, purchasing an additional 1,000,000 units for $10,000,000 , and an additional 15,000 private placement units were sold to the sponsor for $150,000 . A total of $85,212,500 from the IPO and private placements was deposited into the trust account. Transaction costs related to the IPO amounted to $3,408,558 , comprising $1,275,000 in underwriting fees , $1,700,000 in deferred underwriting fees , $92,195 for Representative Shares , and $341,363 in other offering costs . The company also recognized stock-based compensation expense of $185,345 for founder shares transferred to the CEO and CFO, and $64,350 for founder shares transferred to independent directors.

Business Outlook

Charlton Aria Acquisition Corporation's primary outlook is centered on successfully completing an initial business combination. The company has until April 25, 2026, which is 18 months from the IPO consummation, to complete this combination . This period can be extended twice by an additional three months each time, pushing the deadline to July 25, 2026, or October 25, 2026, for a total of up to 24 months from the IPO . Such extensions require the sponsor or its designees to deposit $850,000 ($0.10 per unit) into the trust account for each three-month extension, up to an aggregate of $1,750,000 .

The company intends to structure its initial business combination such that the post-transaction company will own or acquire 100% of the outstanding equity interests or assets of the target business, or at least 50% or more of the outstanding voting securities to acquire a controlling interest . The target business must have an aggregate fair market value of at least 80% of the value of the assets held in the trust account at the time of signing a definitive agreement, excluding deferred underwriters' fees and taxes payable on interest income . The company expects to incur significant costs in the pursuit of its acquisition plans .

Operationally, the company does not expect to generate any operating revenues until after the completion of its initial business combination . It may generate non-operating income from interest on investments held in the trust account . The company will continue to incur expenses as a public company, including legal, financial reporting, accounting, and auditing compliance costs, as well as due diligence expenses for completing an initial business combination . Management plans to address the identified material weakness in internal controls related to inadequate segregation of duties and insufficient written policies by enhancing the size and composition of its board upon closing the initial business combination, identifying third-party professionals for complex accounting, and considering additional staff with relevant experience and training .

Regarding capital allocation, the company intends to use funds held outside the trust account primarily to identify and evaluate target businesses, perform due diligence, travel, review corporate documents, and structure, negotiate, and complete an initial business combination . To fund working capital deficiencies or transaction costs, the company's insiders, officers, and directors, or their affiliates, may loan funds, up to $3,000,000, which may be convertible into units at $10.00 per unit at the lender's option . As of December 31, 2024, there were no borrowings under these Working Capital Loans . The company does not believe it will need to raise additional funds for operating its business, but acknowledges that if estimated costs for identifying and completing a target business are insufficient, it may need additional financing, potentially through dilutive equity issuances or debt .

Risk Factors

The company faces several material risks, primarily stemming from its nature as a blank check company. A significant risk is the uncertainty surrounding its ability to complete an initial business combination within the Combination Deadline of April 25, 2026, which can be extended up to October 25, 2026, with additional sponsor deposits . Failure to consummate a business combination by this deadline would result in the company ceasing operations, redeeming public shares at a per-share price equal to the aggregate amount in the trust account (less up to $100,000 for dissolution expenses), and then liquidating and dissolving . The proceeds deposited in the trust account could become subject to claims of the company's creditors, which may have priority over public shareholders' claims . The sponsor has agreed to be liable for claims that reduce the trust account below $10.025 per public share or the actual amount per public share, if less, but the company has not verified the sponsor's ability to satisfy these obligations . The company also faces intense competition from other entities with similar business objectives, including other blank check companies, private equity groups, and public companies, many of which possess greater financial, technical, and human resources . The obligation to pay cash for public shareholders exercising redemption rights may reduce resources available for an initial business combination, potentially placing the company at a competitive disadvantage . Furthermore, the ongoing military action in Ukraine and related economic sanctions could materially and adversely affect the company's ability to consummate an initial business combination or the operations of a target business, potentially impacting the availability of equity and debt financing due to increased market volatility or decreased market liquidity . The company has also identified a material weakness in its internal controls over financial reporting due to inadequate segregation of duties and insufficient written policies and procedures for accounting, IT, and financial reporting .

Management Priorities

Management's message to shareholders emphasizes the company's strategic focus on identifying and evaluating suitable target businesses to complete an initial business combination. They highlight the company's structure as an attractive alternative to a traditional IPO for target businesses, offering a potentially more expeditious and cost-effective method to becoming public . Management's strategic priorities include leveraging their experience to improve operational efficiency and scale revenue organically or through acquisitions, seeking targets with strong management, underexploited expansion opportunities, long-term revenue visibility, and those that would benefit from public company status . The company has a clear timeline to complete an initial business combination by April 25, 2026, with potential extensions up to October 25, 2026, contingent on sponsor deposits of $850,000 per three-month extension, up to an aggregate of $1,750,000 . Management also acknowledges the need to address internal control weaknesses by enhancing board composition and seeking third-party expertise .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — General
  2. [2] Item 1, Business — General
  3. [3] Item 1, Business — General
  4. [4] Item 1, Business — Status as a Public Company
  5. [5] Item 1, Business — Business Strategy and Acquisition Criteria
  6. [6] Item 1, Business — Business Strategy and Acquisition Criteria
  7. [7] Item 1, Business — Business Strategy and Acquisition Criteria
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 7, MD&A — Results of Operations
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Results of Operations
  13. [13] Item 7, MD&A — Results of Operations
  14. [14] Item 7, MD&A — Liquidity and Capital Resources
  15. [15] Item 7, MD&A — Liquidity and Capital Resources
  16. [16] Item 8, Balance Sheet — Total Current Assets
  17. [17] Item 8, Balance Sheet — Total Assets
  18. [18] Item 8, Balance Sheet — Total Current Liabilities
  19. [19] Item 8, Balance Sheet — Accounts payable and accrued expenses
  20. [20] Item 8, Balance Sheet — Due to related parties
  21. [21] Item 8, Balance Sheet — Deferred underwriting commission payable
  22. [22] Item 8, Balance Sheet — Total Liabilities
  23. [23] Item 8, Balance Sheet — Total Shareholders’ Deficit
  24. [24] Item 8, Balance Sheet — Accumulated deficit
  25. [25] Item 7, MD&A — Results of Operations
  26. [26] Item 7, MD&A — Results of Operations
  27. [27] Item 7, MD&A — Results of Operations
  28. [28] Item 7, MD&A — Results of Operations
  29. [29] Item 7, MD&A — Our Initial Public Offering
  30. [30] Item 7, MD&A — Our Initial Public Offering
  31. [31] Item 7, MD&A — Our Initial Public Offering
  32. [32] Item 7, MD&A — Our Initial Public Offering
  33. [33] Item 7, MD&A — Liquidity and Capital Resources
  34. [34] Item 7, MD&A — Liquidity and Capital Resources
  35. [35] Item 7, MD&A — Liquidity and Capital Resources
  36. [36] Item 7, MD&A — Liquidity and Capital Resources
  37. [37] Item 7, MD&A — Liquidity and Capital Resources
  38. [38] Item 7, MD&A — Liquidity and Capital Resources
  39. [39] Item 5, Recent Sales of Unregistered Securities — Founder Shares Sales and Transfer
  40. [40] Item 5, Recent Sales of Unregistered Securities — Founder Shares Sales and Transfer
  41. [41] Item 1, Business — Initial Business Combination
  42. [42] Item 1, Business — Initial Business Combination
  43. [43] Item 1, Business — Initial Business Combination
  44. [44] Item 1, Business — Initial Business Combination
  45. [45] Item 1, Business — Initial Business Combination
  46. [46] Item 7, MD&A — Overview
  47. [47] Item 7, MD&A — Results of Operations
  48. [48] Item 7, MD&A — Results of Operations
  49. [49] Item 7, MD&A — Results of Operations
  50. [50] Item 9A, Controls and Procedures — Management’s Report on Internal Controls over Financial Reporting
  51. [51] Item 7, MD&A — Liquidity and Capital Resources
  52. [52] Item 7, MD&A — Liquidity and Capital Resources
  53. [53] Item 7, MD&A — Liquidity and Capital Resources
  54. [54] Item 7, MD&A — Liquidity and Capital Resources
  55. [55] Item 1, Business — Initial Business Combination
  56. [56] Item 1, Business — Redemption of Public Shares and Liquidation if No Initial Business Combination
  57. [57] Item 1, Business — General
  58. [58] Item 1, Business — Redemption Rights for Public Shareholder upon Completion of Our Initial Business Combination
  59. [59] Item 1, Business — Redemption of Public Shares and Liquidation if No Initial Business Combination
  60. [60] Item 1, Business — Competition
  61. [61] Item 1, Business — Competition
  62. [62] Item 1, Note 1 — Risks and Uncertainties
  63. [63] Item 9A, Controls and Procedures — Management’s Report on Internal Controls over Financial Reporting
  64. [64] Item 1, Business — Status as a Public Company
  65. [65] Item 1, Business — Business Strategy and Acquisition Criteria
  66. [66] Item 1, Business — Initial Business Combination
  67. [67] Item 9A, Controls and Procedures — Management’s Report on Internal Controls over Financial Reporting

Analysis on 5/20/2026